Heimfeld S - Search Results

1

BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.

Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Verfaillie CM, et al. Among authors: heimfeld s. Blood. 1996 Jun 1;87(11):4770-9. Blood. 1996. PMID: 8639848 Free article.

2

Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.

Brugger W, Henschler R, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Brugger W, et al. Among authors: heimfeld s. Blood. 1994 Sep 1;84(5):1421-6. Blood. 1994. PMID: 7520769 Free article. Clinical Trial.

3

Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.

Brugger W, Möcklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Brugger W, et al. Among authors: heimfeld s. Blood. 1993 May 15;81(10):2579-84. Blood. 1993. PMID: 7683923 Free article.

4

Collection of blood stem cells from patients with sickle cell anemia.

Richard RE, Siritanaratkul N, Jonlin E, Skarpidi E, Heimfeld S, Blau CA. Richard RE, et al. Among authors: heimfeld s. Blood Cells Mol Dis. 2005 Nov-Dec;35(3):384-8. doi: 10.1016/j.bcmd.2005.06.014. Epub 2005 Aug 26. Blood Cells Mol Dis. 2005. PMID: 16125985

5

Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.

Ruggieri L, Heimfeld S, Broxmeyer HE. Ruggieri L, et al. Among authors: heimfeld s. Blood Cells. 1994;20(2-3):436-54. Blood Cells. 1994. PMID: 7538350

6

A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.

Shpall EJ, LeMaistre CF, Holland K, Ball E, Jones RB, Saral R, Jacobs C, Heimfeld S, Berenson R, Champlin R. Shpall EJ, et al. Among authors: heimfeld s. Blood. 1997 Dec 1;90(11):4313-20. Blood. 1997. PMID: 9373242 Free article. Clinical Trial.

7

Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector.

von Kalle C, Kiem HP, Goehle S, Darovsky B, Heimfeld S, Torok-Storb B, Storb R, Schuening FG. von Kalle C, et al. Among authors: heimfeld s. Blood. 1994 Nov 1;84(9):2890-7. Blood. 1994. PMID: 7524756 Free article.

8

Male DNA in female donor apheresis and CD34-enriched products.

Adams KM, Lambert NC, Heimfeld S, Tylee TS, Pang JM, Erickson TD, Nelson JL. Adams KM, et al. Among authors: heimfeld s. Blood. 2003 Nov 15;102(10):3845-7. doi: 10.1182/blood-2003-05-1570. Epub 2003 Jul 17. Blood. 2003. PMID: 12869496 Free article.

9

Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.

Holmberg LA, Boeckh M, Hooper H, Leisenring W, Rowley S, Heimfeld S, Press O, Maloney DG, McSweeney P, Corey L, Maziarz RT, Appelbaum FR, Bensinger W. Holmberg LA, et al. Among authors: heimfeld s. Blood. 1999 Dec 15;94(12):4029-35. Blood. 1999. PMID: 10590046 Free article. Clinical Trial.

10

Culture of phenotypically defined hematopoietic stem cells and other progenitors at limiting dilution on Dexter monolayers.

Weilbaecher K, Weissman I, Blume K, Heimfeld S. Weilbaecher K, et al. Among authors: heimfeld s. Blood. 1991 Aug 15;78(4):945-52. Blood. 1991. PMID: 1678290 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page